Drug intelligence / Profile preview

intranasal clonazepam

Development stage
Unknown
Lead developer
Jazz Pharmaceuticals
Modality
Small Molecules
Administration
Intranasal
01

Overview

Intranasal clonazepam (JZP-323) is a benzodiazepine derivative developed as a rescue medication for the treatment of acute repetitive seizures in patients with epilepsy. It is a proprietary intranasal spray formulation of clonazepam designed to provide rapid systemic absorption and a fast onset of action during or immediately following a seizure event. As a positive allosteric modulator of the **GABA-A receptor**, it enhances the inhibitory effects of gamma-aminobutyric acid (GABA) in the central nervous system, effectively suppressing the hypersynchronous neuronal firing that characterizes epileptic activity. This formulation offers a non-invasive alternative to traditional rescue therapies such as rectal gels or intravenous injections, facilitating easier administration by caregivers in outpatient settings.

Other names
clonazepam nasal sprayclonazepam intranasalintranasal clonazepam spray
02

Targets

GABRR (GABA-A receptor subunit rho)

Beyond the preview

Go deeper on intranasal clonazepam.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on intranasal clonazepam.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call